registration review complete
on 30 Apr 2024
Last Applicant/ Owned by
17 Lee Boulevard
Malvern
US
19355
Serial Number
97796226 filed on 15th Feb 2023
Registration Number
N/A
Correspondent Address
Christopher . Olszyk, Jr.OX ROTHSCHIL LLP
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; Research and development in the fields of bioanalysis, immunoassay development, bioanalytical assay validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; Pharmaceutical research and development services; Chemical,Read More
Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; Research and development in the fields of bioanalysis, immunoassay development, bioanalytical assay validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; Pharmaceutical research and development services; Chemical, bioanalytical, biological and biotechnology research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Pharmaceutical drug development services; Scientific testing in the fields of oncology, neurology, gastroenterology, immunology, endocrinology, gene therapy, infectious disease, rare and orphan diseases, cardiovascular disease, metabolic disease, central nervous system, ophthalmology, and respiratory diseases, for medical and pharmaceutical research purposes; rug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; Scientific analytical laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development
17th May 2023
17th May 2023
No 97796226
No Service Mark
No 032735.00051
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
30th Apr 2024 | ALLOWE PRINCIPAL REGISTER - SOU ACCEPTE |
30th Apr 2024 | NOTICE O ACCEPTANCE O STATEMENT O USE E-MAILE |
19th Apr 2024 | STATEMENT O USE PROCESSING COMPLETE |
19th Apr 2024 | CASE ASSIGNE TO INTENT TO USE PARALEGAL |
01st Apr 2024 | TEAS STATEMENT O USE RECEIVE |
01st Apr 2024 | USE AMENMENT ILE |
05th Mar 2024 | NOA E-MAILE - SOU REQUIRE ROM APPLICANT |
09th Jan 2024 | OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE |
09th Jan 2024 | PUBLISHE OR OPPOSITION |
20th Dec 2023 | NOTIICATION O NOTICE O PUBLICATION E-MAILE |